教育经历

2011-2016 博士，新加坡国立大学，生物医药工程

2004-2008 本科，新加坡国立大学，生物医药工程

工作经历

2022.03-至今   助理教授，南方科技大学

2018-2022     副研究员，中国科学院深圳先进技术研究院

代表性论文

1. Xu, G., Li, Y., Zhang, S., Peng, H., Wang, Y., Li, D., Jin, T., He, Z., Tong, Y., Qi, C., Wu, G., Dong, K., Gou, J., Liu, Y., Xiao, T., Qu, J., Li,L. （李亮，通讯作者）, Liu, L., Zhao, P., Zhang, Z., Yuan, J.. (2021) SARS-CoV-2 promotes RIPK1 activation to facilitate viral propagation. Cell Research. 0:1 – 14. (IF = 25.617)

2. He,Y., Qu, J., Wei, L., Liao, S., Zheng, N., Liu, Y., Wang, X., Jing, Y., Shen, C.K., Ji, C., Luo, G., Zhang, Y., Li, S., Fan, Y., Fang, S., Wang, P., Li,L. （李亮，通讯作者）. (2021) Generation and Effect Testing of a SARS-CoV-2 RBD-Targeted Polyclonal Therapeutic Antibody Based on Airway Organoid Screening System. Frontiers in Immunology. 12:689065 (IF=7.561)

3. Tang, M., Li, S., Wei, L., Qu, J., Li, L. （李亮，通讯作者）. (2021) Do engineered nanomaterials affect immune responses by interacting with gut microbiota? Frontiers in Immunology. 12:684605 (IF=7.561)

4. Yang, M., Li, L.（李亮，共一作者）, Huang, T., Li, S., Zhang, M., Yang, Y., Jiang, Y., Li, X., Yuan, J., Liu, Y.. (2021) SARS-CoV-2 Detected on Environmental Fomites for both Asymptomatic and Symptomatic COVID-19 Patients. American Journal of Respiratory and Critical Care Medicine. rccm.202006-2136LE (IF: 21.405)

5. Zhao, F., Yang, Y., Wang, Z., Li, L.（李亮，通讯作者）, Liu, L., Liu, Y.. (2020) The Time Sequences of Oral and Fecal Viral Shedding of Coronavirus Disease 2019 (COVID-19) Patients. Gastroenterology S0016-5085(20)30663-6 (IF: 22.682)

6. Shi, Y., Lin, J., Tao, X., Qu, J., Liao, S., Li, M., Deng, K., Du, P., Liu, K., Thissen, H., Li, L. (李亮，通讯作者), Kingshott, P., and Wang, P-Y. (2021) Harnessing Colloidal Self-Assembled Patterns (cSAPs) to Regulate Bacterial and Human Stem Cell Response at Biointerfaces In Vitro and In Vivo. ACS Appl. Mater. Interfaces. 2021, 13, 18, 20982–20994 (IF: 9.229)

7. Li, L.（李亮，第一作者）, Chong, H.C., Ng, S.Y., Kwok, K.W., Teo, Z., Tan, E.H.P., Choo, C.C., Seet, J.E., Choi. H.W., Buist, M.L., Chow, V.T.K., Tan, N.S. (2015) Angiopoietin-like 4 increases pulmonary tissue leakiness and damage during influenza pneumonia. Cell Rep. 10(5): 654-663 (IF: 9.423)

8. Li, L.（李亮，第一作者，通讯作者）,Foo, B.J.W., Kwok, K.W., Sakamoto, N., Mukae, H., Izumikawa, K., Mandard, S., Quenot, J.-P., Lagrost, L., Teh, W.K., Kohli, G.S., Zhu, P., Choi, H., Buist, M.L., Yang, L., He, F., Chow, V.T.K., Tan, N.S.. (2019) Antibody treatment against angiopoietin-like 4 (ANGPTL4) reduces pulmonary edema and injury in secondary pneumococcal pneumonia. mBio 10:e02469-18. (IF: 6.784，中科院小类一区，TOP期刊)

9. Liang, L., Li, L.（李亮，通讯作者）, Rong, F.. (2020) Serum Creatinine as a Potential Biomarker for the Diagnosis of Tuberculous Pleural Effusion. Am. J. Med. Sci. (IF: 1.962)

10. Davient, B., Ng, J.P.Z., Xiao, Q., Li, L.（李亮，通讯作者）, and Yang, L..(2018) Comparative Transcriptomics Unravels Prodigiosin's Potential Cancer-Specific Activity Between Human Small Airway Epithelial Cells and Lung Adenocarcinoma Cells. Front. Oncol. 8:573 (IF: 4.848)